MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202518047513 A) filed by Scynexis, Inc., Jersey City, U.S.A., on May 16, for 'antifungal agents used in combination.'
Inventor(s) include Angulo Gonzalez, David A.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to the use of enfumafungin derivative triterpenoid antifungal compounds in combination with other antifungal agents such azoles,polyenes, lipopeptides, and allylamides to treat fungal diseases. More particularly, the invention relates to antifungal combinations of enfumafungin derivative triterpenoids which are inhibitors of (1,3)-?-D-glucan synthesis, in combination with other antifungal agents such as mold-active agents that have activity against molds, including but not limited to voriconazole, isavuconazole, posaconazole,itraconazole and amphotericin B, for the treatment and/or prevention of infections caused by molds."
The patent application was internationally filed on Apr. 04, 2018, under International application No.PCT/US2018/026088.
Disclaimer: Curated by HT Syndication.
